Can a tiny implant seal large artery holes faster and safer?
NCT ID NCT07719244
First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time
Summary
This study tests a new device called the xDot Access Management System, designed to close large puncture sites in the femoral artery and vein after catheter-based procedures. The device delivers a small implant around the access site to stop bleeding. Researchers are measuring how quickly bleeding stops and whether major complications occur, aiming to see if the device is safe and effective for routine use.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a device called the xDot Access Management System (AMS) that delivers an implant to close the puncture site in the femoral artery or vein
- What this could lead to
- If successful, this device could provide a faster, safer way to close large puncture sites after catheter procedures, reducing complications and recovery time.
- What could go wrong
- This is a pivotal study, but the device is still investigational. It may not work as intended or could cause complications like bleeding or infection at the access site.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VASCULAR CLOSURE DEVICES are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.